Ascentage Pharma Group International (AAPG) Intangibles (2022 - 2025)

Ascentage Pharma Group International (AAPG) has reported Intangibles for 4 consecutive years, with $9.3 million the latest figure, recorded in Q4 2025.

• Quarterly Intangibles fell 12.13% year-over-year to $9.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.3 million (down 12.13% YoY) and the FY2025 annual result came in at $9.4 million, down 9.44% from the prior year.
• Intangibles eased to $9.3 million in Q4 2025 per AAPG's latest filing, from $9.9 million in the prior quarter.
• Over the last five years, Intangibles for AAPG reached as high as $10.6 million in Q4 2024 and fell as low as $3.8 million in Q4 2023.
• A 4-year average of $7.5 million and a median of $9.3 million in 2025 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2024 — Intangibles jumped 180.84% — and 2025, when it dropped 12.13%.
• Year by year, Intangibles stood at $4.0 million in 2022, then dropped by 6.4% to $3.8 million in 2023, then soared by 180.84% to $10.6 million in 2024, then retreated by 12.13% to $9.3 million in 2025.
• According to Business Quant data, Intangibles over the past three periods registered $9.3 million, $9.9 million, and $10.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.